These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6518777)

  • 21. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.
    Lieberman R; Nelson WG; Sakr WA; Meyskens FL; Klein EA; Wilding G; Partin AW; Lee JJ; Lippman SM
    Urology; 2001 Apr; 57(4 Suppl 1):4-27. PubMed ID: 11295590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
    Antithrombotic Trialists' Collaboration
    BMJ; 2002 Jan; 324(7329):71-86. PubMed ID: 11786451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effectiveness of interventions in managing treatment adherence in adult heart transplant patients: a systematic review.
    Marcelino CA; Díaz LJ; da Cruz DM
    JBI Database System Rev Implement Rep; 2015 Sep; 13(9):279-308. PubMed ID: 26470673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationale and design of the on-treatment PLAtelet Reactivity-Guided Therapy Modification FOR ST-Segment Elevation Myocardial Infarction (PLATFORM) randomized trial.
    Mrdovic I; Savic L; Krljanac G; Asanin M; Cvetinovic N; Brdar N; Stojanovic M; Djuricic N; Stankovic S; Marinkovic J; Perunicic J
    J Interv Cardiol; 2013 Jun; 26(3):221-7. PubMed ID: 23373620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discrepancies in assessment of adherence to antiplatelet treatment after myocardial infarction.
    Kubica A; Kasprzak M; Obońska K; Fabiszak T; Laskowska E; Navarese EP; Koziński M; Sztuba B; Świątkiewicz I; Grześk G; Kubica J
    Pharmacology; 2015; 95(1-2):50-8. PubMed ID: 25592409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of high risk of non-adherence to antiplatelet treatment.
    Kubica A; Obońska K; Kasprzak M; Sztuba B; Navarese EP; Koziński M; Świątkiewicz I; Kieszkowska M; Ostrowska M; Grześk G; Kubica J
    Kardiol Pol; 2016; 74(1):61-7. PubMed ID: 26101025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated telephone communication systems for preventive healthcare and management of long-term conditions.
    Posadzki P; Mastellos N; Ryan R; Gunn LH; Felix LM; Pappas Y; Gagnon MP; Julious SA; Xiang L; Oldenburg B; Car J
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD009921. PubMed ID: 27960229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Course control of platelet function and blood lipid levels during a 2 years prospective study on the prevention of reinfarction with acetylsalicylic acid, phenprocoumon and placebo].
    Walter E; Weber E; Loew D
    Verh Dtsch Ges Inn Med; 1978; (84):1481-5. PubMed ID: 369187
    [No Abstract]   [Full Text] [Related]  

  • 29. Recruitment in the Coronary Drug Project and the Aspirin Myocardial Infarction Study.
    Schoenberger JA
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):681-4. PubMed ID: 373954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance and predictors of recruitment success in National Heart, Lung, and Blood Institute's cardiovascular clinical trials.
    Pemberton VL; Evans F; Gulin J; Rosenberg E; Addou E; Burns KM; Gordon DJ; Pearson GD; Kaltman JR
    Clin Trials; 2018 Oct; 15(5):444-451. PubMed ID: 30084662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does packaging with a calendar feature improve adherence to self-administered medication for long-term use? A systematic review.
    Zedler BK; Kakad P; Colilla S; Murrelle L; Shah NR
    Clin Ther; 2011 Jan; 33(1):62-73. PubMed ID: 21397775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Key clinical activities for quality asthma care. Recommendations of the National Asthma Education and Prevention Program.
    Williams SG; Schmidt DK; Redd SC; Storms W;
    MMWR Recomm Rep; 2003 Mar; 52(RR-6):1-8. PubMed ID: 12696781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trials of platelet-active drugs in coronary heart disease: summary of design features.
    Furberg CD; May GS
    Circulation; 1980 Dec; 62(6 Pt 2):V49-52. PubMed ID: 7002352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug insight: aspirin resistance--fact or fashion?
    Patrono C; Rocca B
    Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):42-50. PubMed ID: 17180149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevention of recurrent myocardial infarcts by long-term aspirin therapy].
    Khalfen ESh; Ivanova IA
    Kardiologiia; 1986 Sep; 26(9):66-70. PubMed ID: 3537440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research programs of the National Heart, Lung, and Blood Institute. Bethesda, Maryland, U.S.A.
    Roth CA; Lenfant C
    Cor Vasa; 1989; 31(2):81-9. PubMed ID: 2743780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet function and response to aspirin: gender-specific features and implications for female thrombotic risk and management.
    Zuern CS; Lindemann S; Gawaz M
    Semin Thromb Hemost; 2009 Apr; 35(3):295-306. PubMed ID: 19452405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin for the prevention of coronary thrombosis: current facts and perspectives.
    Patrono C
    Eur Heart J; 1986 Jun; 7(6):454-9. PubMed ID: 3525167
    [No Abstract]   [Full Text] [Related]  

  • 40. Recruitment experience in the Aspirin Myocardial Infarction Study.
    Schoenberger JA
    Control Clin Trials; 1987 Dec; 8(4 Suppl):74S-78S. PubMed ID: 3440392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.